Table 1

Baseline characteristics of study participants; N=512

Variables	Total N=512	%	HPV negative N=290	%	HPV positive N=222	%
Age
25–34	112	21.8	63	21.7	49	22.1
35–44	118	23.0	64	22.1	54	24.3
45–54	153	29.9	89	30.7	64	28.8
55–60	129	25.2	74	25.5	55	24.8
Marital status
Married	443	86.5	266	91.7	177	79.7
Unmarried	69	13.5	24	8.3	45	20.3
Education level
Primary/none	460	89.8	258	89.0	202	91
Secondary/above	52	10.2	32	11.0	20	9
Employment
Employed	423	82.6	242	83.5	181	81.5
Unemployed	89	17.4	48	16.5	41	18.5
Parity
Nulliparous	21	4.1	11	3.8	10	4.5
1	53	10.3	29	10.0	24	10.8
2	219	42.7	126	43.5	93	41.9
3+	219	42.7	124	42.8	95	42.8
Age at first pregnancy
<18	81	15.8	27	9.3	54	24.3
18–25	353	68.9	244	84.1	109	49.1
>25	78	15.2	19	6.6	59	26.6
Ever screened
Yes	185	36.2	104	35.9	81	36.5
No	327	63.8	186	64.1	141	63.5
Heard about HPV test
Yes	23	4.5	10	3.5	13	5.9
No	489	95.5	280	96.6	209	94.1
HIV status
Positive	65	12.7	35	12.1	30	13.5
Negative	447	87.3	255	87.9	192	86.5
On ART(n=65)
Yes	56	86.2	30	83.3	26	83.9
No	9	13.8	4	11.4	5	16.1
No	1	0.0	1	2.9	0	0

ART, antiretroviral therapy; HPV, human papillomavirus.